Companies/Medtronic plc

Company profile

Medtronic plc

NYSE: MDT · Healthcare · Medical - Devices

PublicHQ Galway, CIK 0001613103Reports USD

#20 of 1,394 Healthcare companies by revenue54th-percentile growth

EA Score

84B+

FH 84DQ 88GM 67SS 99

v0.1 · 65/100 weight · provisional

↑ listing tenure, market scale · ↓ 3-yr revenue growth, revenue growth (YoY)

Methodology →

Revenue TTM

$36.4B

Rev growth YoY (TTM)

+8.4%

Net income (FY)

$4.8B

Employees

95,000

Market cap

$106.5B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$36.4B$36.4B2026

Net income$4.8B$4.8B2026

Operating income$6.5B$6.5B2026

Total assets$93.0B$93.0B2026

Liabilities$43.0B$43.0B2026

Equity$49.5B$49.5B2026

Revenue trend

FY2020 – FY2026 · USD

$7.7B

FY20

$28.9B

FY20

$30.1B

FY21

$31.7B

FY22

$31.2B

FY23

$32.4B

FY24

$33.5B

FY25

$36.4B

FY26

Revenue by segment

Filed disclosures · FY2026

By product

Cardiac and Vascular Group39%

Neuroscience Group28%

Medical Surgical24%

Diabetes Group9%

By geography

UNITED STATES80%

Total Other Countries, Excluding United States and Ireland20%

IRELAND0%

The read

Medtronic plc booked $36.4B in FY2026 revenue, growing 8.4% year over year — about the middle of the pack among Healthcare companies we track, at a 13.2% net margin.

Peers · Healthcare

Bristol-Myers Squibb Company85A McKesson Corporation85A HCA Healthcare, Inc.78B+Elevance Health Inc.85A

Key facts

CEOGeoffrey Straub Martha

SectorHealthcare

IndustryMedical - Devices

HeadquartersGalway, null

ExchangeNYSE: MDT

Employees95,000

IPO date1973-05-02

Latest filings

10-K2026-06-18 8-K2026-06-03 8-K2026-05-18 8-K2026-04-27 8-K2026-03-24 10-Q2026-02-24 8-K2026-02-17 10-Q2025-11-25

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.